Severe COVID-19 infection triggers changes that affect gene expression in immune system stem cells, causing alterations in the body’s immune response, according to a new study by Weill Cornell Medicine and Jackson Laboratory investigators.
A technique that enables scientists to record gene mutations and patterns of gene activity in individual cells has been extended to cover RNA splicing as well, in a study co-led by researchers at Weill Cornell Medicine.
The new additions have expertise in a broad range of computing and information science fields and will shape the next generation of tech leaders and innovators.
A treatment combining two antibodies against the coronavirus SARS-CoV-2 strongly protected high-risk people with early COVID-19 symptoms from hospitalization and death in an international Phase 2/3 clinical trial.
The gift will designate the College Scholar Program as the Robert S. Harrison College Scholar Program, expanding support and funding for student research and summer experiences, creating new connections to Cornell’s New York City campuses and increasing scholarship funds available to undergraduates in A&S.
With Cornell's help, an Amish farmer grows shiitake mushrooms and solves his financial woes, and an entrepreneur and a chef, both from China, use the mushrooms for a sauce that is now on the market.
A study involving more than 3.6 million people who’d already received COVID vaccinations found that offering free Lyft rides to a vaccination site was no more enticing than simply reminding people of the importance of getting boosted.
Weill Cornell Medicine has been awarded a five-year, $4.2 million grant by the National Cancer Institute to investigate the molecular mechanisms by which immune cells interact with Epstein-Barr virus to cause lymphoma, particularly in people living with HIV.
Research on the role of hope in community work, online support groups and moderating online communities received awards at the 2023 Conference on Computer-Supported Cooperative Work And Social Computing.